Skip to main content

NIH Director Dr. Francis Collins and CDC Director Dr Robert Redfield testify during a U.S. Senate Appropriations Subcommittee hearing on the plan to research, manufacture and distribute a coronavirus vaccine, known as Operation Warp Speed on Capitol Hill in Washington, D.C, U.S., July 2, 2020.POOL/Reuters

The U.S. National Institutes of Health’s director said on Thursday that he was optimistic that the Trump administration’s vaccine-acceleration program, Operation Warp Speed, will generate a safe and effective vaccine for COVID-19 by year end and can meet a target of making 300 million doses by early 2021.

“That’s really a stretch goal, but it’s the right goal for the American people,” Dr. Francis Collins said at a hearing held by a subcommittee of the Senate Committee on Appropriations to discuss the program.

U.S. President Donald Trump echoed that optimism, saying three vaccine candidates were looking especially good.

“Three are really, really looking good,” Trump said at an event at the White House, without providing details. “We think we’re going to have it soon.”

The Director of the U.S. National Institutes of Health said Thursday that 'we are all optimistic' that the Trump administration's vaccine-acceleration program will produce a safe and effective vaccine for COVID-19 by year end.

The Associated Press

Dr. Gary Disbrow, acting director of the Biomedical Advanced Research and Development Authority (BARDA), said that the U.S. government was trying to negotiate the lowest possible price for a vaccine. Still, he said that the country would likely have to pay more for any vaccine not developed with government funding.

BARDA has provided funds for three vaccine candidates being developed under Operation Warp Speed by Moderna Inc, Johnson & Johnson and AstraZeneca Plc.

NIH’s Collins also said in his testimony that the United States is targeting having 1 million rapid, on-site tests per day some time around September to enable schools to reopen and sports events.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.